HaiZhu District Introduces 10-Point Policy Offering Up to 10 Million Yuan Support for Brain-Computer Interface Industry

Deep News
Apr 18

HaiZhu District has recently launched the "HaiZhu Brain-Computer Interface Industry 10-Point Policy," providing comprehensive support from R&D and innovation to product commercialization, market expansion, and application scenarios. Companies can receive up to 10 million yuan in financial assistance. Key highlights of the policy include:

- **Innovation Platform Support**: Encourages the establishment of R&D platforms, with annual support of up to 10 million yuan to build a top-tier brain science innovation hub.

- **Technology R&D Support**: Offers a 30% subsidy on R&D expenses, with annual support capped at 3 million yuan, easing financial burdens for core technology development.

- **Certification Application Support**: Provides up to 200,000 yuan for products entering the National Innovative Medical Device Special Review or Priority Registration Process. Additional incentives include up to 1 million yuan for Class III medical device registration and up to 300,000 yuan for Class II medical device registration, accelerating the market entry of innovative products.

- **Product Commercialization Support**: Grants up to 1 million yuan for the production of Class III medical devices and up to 500,000 yuan for Class II medical devices, offering dual rewards from certification to mass production.

- **Product Marketization Support**: Offers up to 5 million yuan annually to help high-quality products capture market share quickly.

- **Overseas Market Expansion Support**: Provides up to 1 million yuan per year to assist companies in expanding globally and building international brands.

- **Business Growth Rewards**: Implements tiered rewards for revenue growth in core business areas, with annual support of up to 2 million yuan. The faster the growth, the higher the reward, with no upper limit.

- **Model Optimization Support**: Covers up to 50% of costs for model inference or training optimization, with annual support reaching 1.5 million yuan, reducing AI model iteration costs and enhancing algorithm efficiency.

- **Incubation Space Support**: Encourages the development of cutting-edge industrial incubation spaces, with annual support of up to 2 million yuan, providing "seedling + acceleration" full-cycle support for startups.

- **Application Scenario Support**: Allocates up to 300,000 yuan annually to foster innovative application scenarios, bridging the gap between laboratory research and real-world implementation.

**Why Choose HaiZhu?** - **Comprehensive Coverage**: Full-chain support from R&D, certification, production, and market expansion to global growth. - **Substantial Funding**: A multi-million-yuan funding pool directly addressing corporate needs. - **Industrial Clustering**: Home to Pazhou Lab and multiple top-tier hospitals, fostering collaboration among industry, academia, and healthcare. - **Regional Hub**: Located within a one-hour reach of Guangzhou, Shenzhen, Hong Kong, and Macao, with access to global brain science resources.

The 10-point brain-computer interface policy aligns with national "15th Five-Year Plan" initiatives for future industries, activating innovation elements such as technology, capital, and talent. It accelerates the development of the brain-computer interface industry ecosystem, positioning HaiZhu District as a nationally influential hub for cutting-edge technological innovation.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10